Company / Accounts Receivable
GRAIL, Inc. Accounts Receivable History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$18.3M
FY2025
5-year range
$16.9M / $20.3M
FY2023-FY2025
Trend
-9.9%
vs FY2024
Sector context
#128 of 138
Health Care
What the data says
Among 138 Health Care companies, GRAIL, Inc. is in the bottom 7% for accounts receivable. Improved from $17M to $18M over the past 2 years.
Based on SEC 10-K filings.
$18M in FY2025.
Improved from $17M to $18M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 138This company $18.3M Sector average $1.3B
▼
-98.6% below sector average
Key checks
Key Insights
- In FY2025, accounts receivable decreased 9.9% year-over-year.
- Ranks #128 out of 138 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.3M | -9.9% |
| FY2024 | $20.3M | +19.9% |
| FY2023 | $16.9M | - |
| FY2022 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026